ResMed, Inc. (RMD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1159917,
    "name": "ResMed, Inc.",
    "stock_name": "ResMed, Inc.",
    "full_name": "ResMed, Inc.",
    "name_url": "stocks-analysis/resmed-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "251.51",
    "chg": 0.07,
    "chgp": "0.03%",
    "dir": 1,
    "prev_price": "251.44",
    "mcapval": "52,608.65",
    "mcap": "Mid Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US7611521078",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "323.96 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/resmed-inc-1159917-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ResMed, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/resmed-inc-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-price-decline-3652054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ResMedInc_technicaldot_3652054.png",
        "date": "2025-10-28 15:34:00",
        "description": "ResMed, Inc. has experienced notable stock price fluctuations, currently priced at $259.21 after a previous close of $265.26. The company has shown mixed technical indicators, with varying trends across different time frames. Its performance has lagged behind the S&P 500 in both short-term and longer-term returns."
      },
      {
        "title": "Is ResMed, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resmed-inc-technically-bullish-or-bearish-3651201",
        "imagepath": "",
        "date": "2025-10-28 11:37:29",
        "description": "As of 24 October 2025, the technical trend for ResMed, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different time frames. The weekly MACD and KST are both mildly bearish, while the monthly MACD remains bullish. The weekly Bollinger Bands indicate a bearish trend, contrasted by a mildly bullish monthly perspective. Daily moving averages show a mildly bullish stance. \n\nIn terms of performance, ResMed has underperformed the S&P 500 over the past week and month, with returns of -3.21% and -5.36% compared to the S&P's gains of 1.92% and 2.32%, respectively. However, year-to-date, ResMed is slightly behind the S&P 500, with a return of 13.47% versus 15.47%. Overall, the mixed indicators suggest a cautious approach...."
      },
      {
        "title": "Is ResMed, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resmed-inc-technically-bullish-or-bearish-3647655",
        "imagepath": "",
        "date": "2025-10-27 11:48:45",
        "description": "As of 24 October 2025, the technical trend for ResMed, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different time frames. The weekly MACD and KST are mildly bearish, while the monthly MACD is bullish. The Bollinger Bands indicate a bearish trend on the weekly chart but mildly bullish on the monthly. Daily moving averages are mildly bullish, suggesting some short-term strength. Overall, the stock has underperformed the S&P 500 over the past week and month, with returns of -3.21% and -5.36% compared to the S&P's 1.92% and 2.32%, respectively...."
      },
      {
        "title": "Is ResMed, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resmed-inc-technically-bullish-or-bearish-3646190",
        "imagepath": "",
        "date": "2025-10-26 11:23:27",
        "description": "As of 24 October 2025, the technical trend for ResMed, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different time frames. The weekly MACD and KST are both mildly bearish, while the monthly MACD remains bullish. The Bollinger Bands indicate a bearish signal on the weekly chart but a mildly bullish signal on the monthly chart. Daily moving averages show a mildly bullish trend. \n\nIn terms of performance, ResMed has underperformed the S&P 500 over the past week and month, with returns of -3.21% and -5.36% compared to the S&P's 1.92% and 2.32%, respectively. However, year-to-date, ResMed has a return of 13.47%, slightly below the S&P 500's 15.47%. Over longer periods, the stock has significantly lagged behind the S&P 500, particularly in the 3-year and 5-year returns...."
      },
      {
        "title": "Is ResMed, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resmed-inc-overvalued-or-undervalued-3637275",
        "imagepath": "",
        "date": "2025-10-21 11:59:01",
        "description": "As of 17 October 2025, the valuation grade for ResMed, Inc. has moved from fair to attractive, indicating a more favorable assessment of its market position. The company appears to be undervalued, supported by a P/E ratio of 36, a PEG ratio of 1.15, and a robust ROCE of 30.33%. In comparison to peers, ResMed's P/E ratio is slightly higher than Edwards Lifesciences Corp. at 31.17 and Agilent Technologies, Inc. at 27.42, but lower than DexCom, Inc. at 53.65, suggesting a competitive valuation within its industry.\n\nDespite recent underperformance against the S&P 500 over the past week and month, where it returned -1.44% and -1.33% respectively, ResMed has shown resilience with a year-to-date return of 17.23%, outperforming the index's 13.30%. This performance, combined with its attractive valuation metrics, reinforces the view that ResMed is positioned favorably in the market...."
      },
      {
        "title": "ResMed, Inc. Experiences Valuation Adjustment Amid Strong Financial Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/resmed-inc-changes-valuation-grade-from-fair-to-attractive-amid-price-fluctuations-3640898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ResMedInc_valuationdot_3640898.png",
        "date": "2025-10-20 16:50:54",
        "description": "ResMed, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 36 and a price-to-book value of 8.57. Key financial metrics indicate strong operational performance, with a return on capital employed of 30.33% and return on equity of 23.58%, highlighting its competitive position in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is ResMed, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resmed-inc-overvalued-or-undervalued-3631683",
        "imagepath": "",
        "date": "2025-10-19 11:54:45",
        "description": "As of 17 October 2025, the valuation grade for ResMed, Inc. has moved from fair to attractive, indicating a positive shift in its perceived value. The company appears to be undervalued, with a P/E ratio of 36, which is higher than the industry average, and an EV to EBITDA ratio of 25.87. Additionally, the PEG ratio stands at 1.15, suggesting that the stock is reasonably priced relative to its growth potential.\n\nIn comparison to its peers, ResMed, Inc. has a P/E ratio of 37.73, which is higher than Edwards Lifesciences Corp.'s 31.17 but lower than Mettler-Toledo International, Inc.'s 68.83, indicating a competitive positioning within the industry. Furthermore, the company's return over the past year is 11.90%, which lags behind the S&P 500's return of 14.08%, but it has outperformed the index year-to-date with a return of 17.23% compared to 13.30%...."
      },
      {
        "title": "ResMed, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/resmed-inc-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-strong-performance-3601172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ResMedInc_technicaldot_3601172.png",
        "date": "2025-10-07 20:15:59",
        "description": "ResMed, Inc. has recently revised its evaluation amid changing market conditions. The stock is currently priced at $281.38, reflecting a slight increase. Over the past year, it has shown significant performance variability. While it has outperformed the S&P 500 in the short term, longer-term returns remain below the index."
      },
      {
        "title": "Is ResMed, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resmed-inc-technically-bullish-or-bearish-3593476",
        "imagepath": "",
        "date": "2025-10-06 11:59:11",
        "description": "As of 3 October 2025, the technical trend for ResMed, Inc. has changed from mildly bullish to bullish. The daily moving averages indicate a bullish stance, while the weekly MACD is mildly bearish, contrasting with the monthly MACD which is bullish. Bollinger Bands are bullish on both weekly and monthly time frames. The KST shows a bullish monthly trend but is mildly bearish weekly. Dow Theory presents a mildly bullish weekly view but is mildly bearish monthly. \n\nIn terms of performance, ResMed has outperformed the S&P 500 over the year-to-date with a return of 21.82% compared to the S&P 500's 14.18%, although it has lagged behind the benchmark over the longer three-year and five-year periods. Overall, the current technical stance is bullish, supported by strong daily moving averages and consistent bullish signals from Bollinger Bands...."
      }
    ],
    "total": 18,
    "sid": "1159917",
    "stock_news_url": "https://www.marketsmojo.com/news/resmed-inc-1159917"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

ResMed, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-28 15:34:00

ResMed, Inc. has experienced notable stock price fluctuations, currently priced at $259.21 after a previous close of $265.26. The company has shown mixed technical indicators, with varying trends across different time frames. Its performance has lagged behind the S&P 500 in both short-term and longer-term returns.

Is ResMed, Inc. technically bullish or bearish?

2025-10-28 11:37:29

As of 24 October 2025, the technical trend for ResMed, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different time frames. The weekly MACD and KST are both mildly bearish, while the monthly MACD remains bullish. The weekly Bollinger Bands indicate a bearish trend, contrasted by a mildly bullish monthly perspective. Daily moving averages show a mildly bullish stance. In terms of performance, ResMed has underperformed the S&P 500 over the past week and month, with returns of -3.21% and -5.36% compared to the S&P's gains of 1.92% and 2.32%, respectively. However, year-to-date, ResMed is slightly behind the S&P 500, with a return of 13.47% versus 15.47%. Overall, the mixed indicators suggest a cautious approach....

Is ResMed, Inc. technically bullish or bearish?

2025-10-27 11:48:45

As of 24 October 2025, the technical trend for ResMed, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different time frames. The weekly MACD and KST are mildly bearish, while the monthly MACD is bullish. The Bollinger Bands indicate a bearish trend on the weekly chart but mildly bullish on the monthly. Daily moving averages are mildly bullish, suggesting some short-term strength. Overall, the stock has underperformed the S&P 500 over the past week and month, with returns of -3.21% and -5.36% compared to the S&P's 1.92% and 2.32%, respectively....

Is ResMed, Inc. technically bullish or bearish?

2025-10-26 11:23:27

As of 24 October 2025, the technical trend for ResMed, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different time frames. The weekly MACD and KST are both mildly bearish, while the monthly MACD remains bullish. The Bollinger Bands indicate a bearish signal on the weekly chart but a mildly bullish signal on the monthly chart. Daily moving averages show a mildly bullish trend. In terms of performance, ResMed has underperformed the S&P 500 over the past week and month, with returns of -3.21% and -5.36% compared to the S&P's 1.92% and 2.32%, respectively. However, year-to-date, ResMed has a return of 13.47%, slightly below the S&P 500's 15.47%. Over longer periods, the stock has significantly lagged behind the S&P 500, particularly in the 3-year and 5-year returns....

Is ResMed, Inc. overvalued or undervalued?

2025-10-21 11:59:01

As of 17 October 2025, the valuation grade for ResMed, Inc. has moved from fair to attractive, indicating a more favorable assessment of its market position. The company appears to be undervalued, supported by a P/E ratio of 36, a PEG ratio of 1.15, and a robust ROCE of 30.33%. In comparison to peers, ResMed's P/E ratio is slightly higher than Edwards Lifesciences Corp. at 31.17 and Agilent Technologies, Inc. at 27.42, but lower than DexCom, Inc. at 53.65, suggesting a competitive valuation within its industry. Despite recent underperformance against the S&P 500 over the past week and month, where it returned -1.44% and -1.33% respectively, ResMed has shown resilience with a year-to-date return of 17.23%, outperforming the index's 13.30%. This performance, combined with its attractive valuation metrics, reinforces the view that ResMed is positioned favorably in the market....

ResMed, Inc. Experiences Valuation Adjustment Amid Strong Financial Performance Metrics

2025-10-20 16:50:54

ResMed, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 36 and a price-to-book value of 8.57. Key financial metrics indicate strong operational performance, with a return on capital employed of 30.33% and return on equity of 23.58%, highlighting its competitive position in the Pharmaceuticals & Biotechnology sector.

Is ResMed, Inc. overvalued or undervalued?

2025-10-19 11:54:45

As of 17 October 2025, the valuation grade for ResMed, Inc. has moved from fair to attractive, indicating a positive shift in its perceived value. The company appears to be undervalued, with a P/E ratio of 36, which is higher than the industry average, and an EV to EBITDA ratio of 25.87. Additionally, the PEG ratio stands at 1.15, suggesting that the stock is reasonably priced relative to its growth potential. In comparison to its peers, ResMed, Inc. has a P/E ratio of 37.73, which is higher than Edwards Lifesciences Corp.'s 31.17 but lower than Mettler-Toledo International, Inc.'s 68.83, indicating a competitive positioning within the industry. Furthermore, the company's return over the past year is 11.90%, which lags behind the S&P 500's return of 14.08%, but it has outperformed the index year-to-date with a return of 17.23% compared to 13.30%....

ResMed, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals

2025-10-07 20:15:59

ResMed, Inc. has recently revised its evaluation amid changing market conditions. The stock is currently priced at $281.38, reflecting a slight increase. Over the past year, it has shown significant performance variability. While it has outperformed the S&P 500 in the short term, longer-term returns remain below the index.

Is ResMed, Inc. technically bullish or bearish?

2025-10-06 11:59:11

As of 3 October 2025, the technical trend for ResMed, Inc. has changed from mildly bullish to bullish. The daily moving averages indicate a bullish stance, while the weekly MACD is mildly bearish, contrasting with the monthly MACD which is bullish. Bollinger Bands are bullish on both weekly and monthly time frames. The KST shows a bullish monthly trend but is mildly bearish weekly. Dow Theory presents a mildly bullish weekly view but is mildly bearish monthly. In terms of performance, ResMed has outperformed the S&P 500 over the year-to-date with a return of 21.82% compared to the S&P 500's 14.18%, although it has lagged behind the benchmark over the longer three-year and five-year periods. Overall, the current technical stance is bullish, supported by strong daily moving averages and consistent bullish signals from Bollinger Bands....

View All News